XT
CMMB

XTX Topco’s Chemomab Therapeutics CMMB Stock Holding History

XTX Topco’s Portfolio CMMB Stock Details CMMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.9K Sell
15,987
-2,642
-14% -$4.45K ﹤0.01% 3859
2026
Q1 		$29.2K Sell
18,629
-384
-2% -$656 ﹤0.01% 3461
2025
Q4 		$31.4K Buy
+19,013
New +$50.4K ﹤0.01% 2955
2025
Q2 		– Sell
-3,319
Closed -$14.5K – 2462
2025
Q1 		$14.5K Sell
3,319
-2,913
-47% -$20.4K ﹤0.01% 2200
2024
Q4 		$45.1K Buy
6,232
+2,426
+64% +$15.3K ﹤0.01% 1915
2024
Q3 		$23.9K Buy
3,806
+39
+1% +$219 ﹤0.01% 1808
2024
Q2 		$13.9K Buy
+3,767
New +$13K ﹤0.01% 1659
2024
Q1 		– Sell
-7,262
Closed -$14.8K – 1897
2023
Q4 		$14.8K Buy
+7,262
New +$19.1K ﹤0.01% 1392

Other funds holding CMMB

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
PIP
Philadelphia Investment Partners Voorhees, New Jersey $161M AUM
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

XTX Topco's CMMB Position: Q2 2026 in Review

XTX Topco reduced its Chemomab Therapeutics (CMMB) stake by 14% in Q2 2026, selling an estimated $4.45K and leaving 15,987 shares worth $25.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3859.

XTX Topco first reported a position in CMMB in Q4 2023 and has held it in 8 quarters since. The position peaked at $45.1K in Q4 2024. 13 funds tracked by Wall St. Rank hold CMMB as of Q2 2026.

  • XTX Topco held 15,987 shares of Chemomab Therapeutics worth $25.9K as of Q2 2026.
  • XTX Topco sold 2,642 Chemomab Therapeutics shares in Q2 2026, an estimated $4.45K.
  • Chemomab Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3859 holding.
  • XTX Topco first reported a position in Chemomab Therapeutics in Q4 2023 and has held it in 8 quarters since.
  • XTX Topco's Chemomab Therapeutics position peaked at $45.1K in Q4 2024.
  • 13 funds tracked by Wall St. Rank held Chemomab Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.